Dexamphetamine Dosing and Management
Start dexamphetamine at 2.5 mg daily in children aged 3-5 years or 5 mg daily (or 2.5 mg twice daily) in children ≥6 years and adults, titrating by 2.5-5 mg weekly until optimal response, with maximum doses of 40 mg/day total (though rarely up to 50 mg/day may be used), while monitoring for appetite suppression, insomnia, and growth attenuation. 1, 2
Starting Doses by Age Group
Children 3-5 Years
- Initial dose: 2.5 mg once daily in the morning 2
- Titration: Increase by 2.5 mg weekly until optimal response 1, 2
- Maximum rarely exceeds 40 mg/day total 1, 2
Children ≥6 Years and Adolescents
- Initial dose: 5 mg once or twice daily (morning after breakfast, noon after lunch) 1, 2
- Titration: Increase by 2.5-5 mg per dose weekly 1
- Weight consideration: Children <25 kg should not receive single doses >10 mg 1
- Maximum: 40 mg/day total per FDA; expert consensus allows up to 40 mg/day total in rare cases 1, 2
Adults
- Initial dose: 5 mg once or twice daily 1
- Titration: Increase by 5-10 mg weekly until symptom control 1
- Maximum: 40 mg/day per FDA; some adults may require up to 0.9 mg/kg/day or 50 mg/day to cover longer functional days 1, 2
- Document clearly when exceeding standard doses that lower doses were inadequate and higher doses produce no adverse effects 1
Titration Strategy
Two approaches are recommended:
Standard Clinical Titration
- Increase dose weekly by 2.5-5 mg per dose if symptom control inadequate 1
- Obtain parent and teacher ratings (children) or self-ratings (adults) weekly during titration 1
- Contact can be maintained by telephone during dose adjustments 1
- Titration phase typically requires 2-4 weeks 1
Forced Titration Trial
- Patient takes all dose levels (2.5,7.5,10 mg for dexamphetamine) for 1 week each 1
- Collect ratings at each dose level
- Select dose producing most benefit with fewest side effects at follow-up visit 1
- Advantage: Less likely to miss a higher dose that yields additional improvement 1
Recent evidence suggests efficacy plateaus around 25 mg/day in children and adolescents, with increasing discontinuation risk above this dose 3, 4. The optimal dose range balancing benefit and risk is approximately 12-26 mg/day (peak 18-20 mg/day) 4.
Dosing Schedule
- First dose: Upon awakening 1, 2
- Additional doses: 1-2 doses at 4-6 hour intervals 1, 2
- Avoid late evening doses due to insomnia risk 2
- Dexamphetamine has longer half-life than methylphenidate; some children may require only once-daily dosing 1
Common Adverse Effects
The most significant adverse effects are:
Primary Concerns
- Appetite suppression: More severe with dexamphetamine than methylphenidate 1, 5
- Insomnia: More problematic with dexamphetamine due to longer half-life 1, 5
- Growth attenuation: Weight loss averaging -0.56 SDS and height loss -0.41 SDS, primarily occurring early in treatment 6, 7
Emotional/Behavioral Effects (More Severe with Dexamphetamine)
Important Context
Many symptoms attributed to stimulants (e.g., poor concentration, behavioral issues) are actually pre-existing ADHD characteristics that improve with treatment 5. The mean number and severity of "side effects" reported at baseline (before medication) often exceeds those during treatment 5.
Monitoring Guidelines
Pre-Treatment Assessment
- Physical examination including baseline blood pressure, pulse, height, and weight 1
- Cardiac screening: Careful history for cardiac disease, family history of sudden death or ventricular arrhythmia 2
- Tic assessment: Evaluate for motor/verbal tics or Tourette's syndrome 2
- Substance use screening in adolescents before initiating treatment 8
During Titration (Weeks 1-4)
- Weekly contact (visit or telephone) 1
- ADHD rating scales from parents and teachers (children) or self-ratings (adults) 1
- Side effect assessment at each contact 1
- Weight measurement at each visit 1
Maintenance Phase
- Monthly appointments until symptoms stabilized 1
- Children: Annual vital signs during routine physical examination 1
- Adults: Blood pressure and pulse checked quarterly 1
- Weight monitoring at each visit to objectively assess appetite effects 1
- More frequent visits if side effects, comorbid disorders, or adherence concerns 1
Systematic Side Effect Assessment
Ask specifically about: 1
- Insomnia
- Anorexia
- Headaches
- Social withdrawal
- Tics
- Weight loss
Critical Pitfalls and Caveats
When Maximum Dose Doesn't Help
If the top recommended dose produces inadequate response, more is not necessarily better 1. Consider:
- Switching to alternative stimulant (methylphenidate) 1
- Environmental or psychosocial interventions 1
- Reassessment of diagnosis
High-Dose Considerations
When exceeding standard maximum doses (>40 mg/day): 1
- Clearly document inadequate response at lower doses
- Confirm absence of side effects (weight loss, blood pressure increase, agitation)
- Monitor for tolerance
- Growth attenuation is the primary concern; no other serious complications reported in high-dose cohorts 6
Special Populations
Preschool children (4-5 years): Slower metabolism requires lower starting doses and smaller increments; use only for moderate-to-severe dysfunction unresponsive to behavioral therapy 8
Adolescents:
- Monitor for diversion and misuse 8
- Consider longer-acting formulations for driving coverage 8
- Prescription drug monitoring program participation recommended 8
Adults: May require higher total daily doses to cover longer functional days, but this reflects multiple dosings rather than higher individual doses 1
Dexamphetamine vs. Methylphenidate
Dexamphetamine causes greater appetite suppression and sleep problems due to longer half-life 1. Recent head-to-head comparison shows comparable 12-month persistence (56% vs 68%, p=0.15) but greater weight loss with dexamphetamine at 3 months (-1.44 kg vs -0.31 kg, p=0.005) 7.